Table 1.
Dominant sensitivity pattern of the frequently cultured microbes among the study patients (n=95).
| Antibiotics tested |
Pseudomoas aeruginosa
(n=36) No. (%) |
Klebsiella pneumoniae
(n=21)
No. (%) |
Proteus
(n=10) No. (%) |
MRSA
(n=13) No. (%) |
MSSA
(n=6) No. (%) |
|---|---|---|---|---|---|
| Piperacillin+Tazobactum | 29 (80.55) | 17 (80.95) | 7 (70.00) | - | - |
| Imipenem | 23 (63.88) | 16 (76.19) | 10 (100) | - | - |
| Ciprofloxacin | 16 (44.44) | 5 (23.80) | - | - | 3 (50) |
| Polymyxin B | 13 (36.11) | 4 (19.04) | - | - | - |
| Cefoperazone+Salbactum | 11 (30.55) | 13 (61.90) | 7 (70.00) | - | - |
| Amikicin | 3 (8.33) | 13 (61.90) | 5 (50.00) | - | - |
| Levofloxacin | 2 (5.55) | 14 (66.66) | 3 (30.00) | - | - |
| Ceftazidime | 4 (11.11) | 5 (23.80) | - | - | - |
| Vancomycin | - | - | - | 13 (100) | 6 (100) |
| Fusidic acid | - | - | - | 9 (69.23) | 6 (100) |
| Linezolid | - | - | - | 13 (100) | 6 (100) |
| Chloramphenicol | - | - | - | 9 (69.23) | 4 (66.66) |
| Cloxacillin | - | - | - | - | 5 (88.33) |